gene_symbol
CD19
hgnc_id
HGNC:1633
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Blinatumomab links CD3 on T cells to CD19 on target cells, inducing an immunologic synapse and T‑cell activation that kills CD19+ cells via perforin/granzyme-dependent cytolysis (MHC-independent).
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
B-cell antigen on leukemic blasts
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05931757
disease_id_num_tar_ref
1729
drug_id_num_tar_ref
4667